-
1
-
-
56849100118
-
"Augmentation treatment in major depressive disorder: Focus on aripiprazole" Neuropsychiatr
-
J C Nelson, A Pikalov, R M Berman. "Augmentation treatment in major depressive disorder: focus on aripiprazole" Neuropsychiatr. Dis. Treat. 2008; 4: 937-948.
-
(2008)
Dis Treat
, vol.4
, pp. 937-948
-
-
Nelson, J.C.1
Pikalov, A.2
Berman, R.M.3
-
2
-
-
34548140086
-
Detection and quantification of aripiprazole and its metabolite, dehydroaripiprazole, by gas chromatography-mass spectrometry in blood samples of psychiatric patients
-
HC Huang, CH Liuok, TH Lan, TM Hu, HJ Chiu, YC Wu. "Detection and quantification of aripiprazole and its metabolite, dehydroaripiprazole, by gas chromatography-mass spectrometry in blood samples of psychiatric patients" J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007; 856: 57-61.
-
(2007)
J. Chromatogr. B Analyt. Technol. Biomed Life Sci.
, vol.856
, pp. 57-61
-
-
Huang, H.C.1
Liuok, C.H.2
Lan, T.H.3
Hu, T.M.4
Chiu, H.J.5
Wu, Y.C.6
-
3
-
-
4344714861
-
Aripiprazole: Review of its use in schizophrenia and schizoaffective disorder
-
SH Tracy, MP Carolin. "Aripiprazole: review of its use in schizophrenia and schizoaffective disorder" Drugs 2004; 64: 1715-1736.
-
(2004)
Drugs
, vol.64
, pp. 1715-1736
-
-
Tracy, S.H.1
Carolin, M.P.2
-
4
-
-
0037177358
-
The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor
-
S Jordan, R Chen, V Koprivica, K Tottori, T Kikuchi, CA Altar. "The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor" Eur. J. Pharmacol. 2002: 441: 137-140.
-
(2002)
Eur. J. Pharmacol.
, vol.441
, pp. 137-140
-
-
Jordan, S.1
Chen, R.2
Koprivica, V.3
Tottori, K.4
Kikuchi, T.5
Altar, C.A.6
-
5
-
-
35348854954
-
Differences in agonist / antagonist properties at human dopamine D2 receptors between aripiprazole, bifeprunox and SDZ208-912
-
Y Tadori, H Kitagawa, RA Forbes, RD McQuade, A Stark, T Kikuchi. "Differences in agonist / antagonist properties at human dopamine D2 receptors between aripiprazole, bifeprunox and SDZ208-912"Eur. J. Pharmacol.2007; 574: 103-111.
-
(2007)
Eur. J. Pharmacol.
, vol.574
, pp. 103-111
-
-
Tadori, Y.1
Kitagawa, H.2
Forbes, R.A.3
McQuade, R.D.4
Stark, A.5
Kikuchi, T.6
-
6
-
-
53549119665
-
Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors
-
Y. Tadori, R.A. Forbes, R.D. McQuade, T. Kikuchi. Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors. Eur J Pharmacol 2008; 597: 27-33.
-
(2008)
Eur J Pharmacol
, vol.597
, pp. 27-33
-
-
Tadori, Y.1
Forbes, R.A.2
McQuade, R.D.3
Kikuchi, T.4
-
7
-
-
9944225707
-
Aripiprazole: Anew atypical antipsychotic with a different pharmacological mechanism
-
D. Naber, M. Lambert. "Aripiprazole: anew atypical antipsychotic with a different pharmacological mechanism" Prog Neuropsychopharmacol Biol Psychiatry. 2004; 28: 1213-1219.
-
(2004)
Prog Neuropsychopharmacol Biol Psychiatry.
, vol.28
, pp. 1213-1219
-
-
Naber, D.1
Lambert, M.2
-
8
-
-
40849097323
-
Analysis of the recent antipsychotic aripiprazole in human serum by capillary electrophoresis and high-performance liquid chromatography with diode array detection
-
Musenga, MA Saracino, D Spinelli, E Rizzato, G Boncompagni, E Kenndler. "Analysis of the recent antipsychotic aripiprazole in human serum by capillary electrophoresis and high-performance liquid chromatography with diode array detection"Anal. Chim. Acta. 2008; 612: 204-211.
-
(2008)
Anal Chim Acta
, vol.612
, pp. 204-211
-
-
Musenga1
Saracino, M.A.2
Spinelli, D.3
Rizzato, E.4
Boncompagni, G.5
Kenndler, E.6
-
9
-
-
20344371199
-
High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat serum and brain:Application to the pharmacokinetic study
-
Y Shimokawa, H Akiyama, E Kashiyama, T Koga, G Miyamoto. "High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat serum and brain:application to the pharmacokinetic study" J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005; 821: 8-14.
-
(2005)
J. Chromatogr. B Analyt. Technol. Biomed Life Sci.
, vol.821
, pp. 8-14
-
-
Shimokawa, Y.1
Akiyama, H.2
Kashiyama, E.3
Koga, T.4
Miyamoto, G.5
-
10
-
-
42749089623
-
Development and validation of a high-performance liquid chroma-tography method using diode array detection for the simultaneous quantification of aripiprazole and dehydro-aripiprazole in human serum
-
F Lancelin, K Djebrani, K Tabaouti, L Kraoul, S Brovedani, P Paubel. "Development and validation of a high-performance liquid chroma-tography method using diode array detection for the simultaneous quantification of aripiprazole and dehydro-aripiprazole in human serum" J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.2008; 867: 15-19.
-
(2008)
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.
, vol.867
, pp. 15-19
-
-
Lancelin, F.1
Djebrani, K.2
Tabaouti, K.3
Kraoul, L.4
Brovedani, S.5
Paubel, P.6
-
11
-
-
70349243082
-
Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human serum by HPLC-MS
-
E Choong, S Rudaz, A Kottelat, D Guillarme, JL Veuthey, CB Eap. "Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human serum by HPLC-MS" J. Pharm. and Biomed. Anal. 2009; 50: 1000-1018.
-
(2009)
J. Pharm. and Biomed Anal.
, vol.50
, pp. 1000-1018
-
-
Choong, E.1
Rudaz, S.2
Kottelat, A.3
Guillarme, D.4
Veuthey, J.L.5
Eap, C.B.6
-
12
-
-
33749431256
-
Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: A multi-level, single-sample approach
-
H Kirchherr, Kuhn-Velten WN. "Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach" J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci. 2006 843: 100-113.
-
(2006)
J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci.
, vol.843
, pp. 100-113
-
-
Kirchherr, H.1
Kuhn-Velten, W.N.2
-
13
-
-
22244478615
-
Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human serum
-
M Kubo, Y Mizooku, Y Hirao, T Osumi. "Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human serum" J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005; 822: 294-299.
-
(2005)
J. Chromatogr. B Analyt. Technol. Biomed Life Sci.
, vol.822
, pp. 294-299
-
-
Kubo, M.1
Mizooku, Y.2
Hirao, Y.3
Osumi, T.4
-
14
-
-
58149380400
-
Development of an LCMS/MS method for the simultaneous quantification of aripiprazole and dehydroaripiprazole in human serum
-
M Song, X Xu, T Hang, A Wen, L Yang. Development of an LCMS/MS method for the simultaneous quantification of aripiprazole and dehydroaripiprazole in human serum. Anal. Biochem.2009; 385: 270-277.
-
(2009)
Anal. Biochem.
, vol.385
, pp. 270-277
-
-
Song, M.1
Xu, X.2
Hang, T.3
Wen, A.4
Yang, L.5
-
15
-
-
34247202104
-
Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of a typical antipsychotics and some metabolites in invitro samples
-
K Y Li, Y G Zhou, HY Ren, F Wang, BK Zhang, HD Li. "Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of a typical antipsychotics and some metabolites in invitro samples" J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007; 850: 581-585.
-
(2007)
J. Chromatogr. B Analyt. Technol. Biomed Life Sci.
, vol.850
, pp. 581-585
-
-
Li, K.Y.1
Zhou, Y.G.2
Ren, H.Y.3
Wang, F.4
Zhang, B.K.5
Li, H.D.6
-
16
-
-
84858302105
-
-
US Department of Health and Human Services, Food and Drug Administration
-
US Department of Health and Human Services, Food and Drug Administration, 2001
-
(2001)
-
-
-
17
-
-
0345424863
-
-
Bioanalytical Method Validation
-
Guidance for Industry, Bioanalytical Method Validation.
-
Guidance for Industry
-
-
|